Your browser doesn't support javascript.
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States.
Fried, Michael W; Crawford, Julie M; Mospan, Andrea R; Watkins, Stephanie E; Munoz, Breda; Zink, Richard C; Elliott, Sherry; Burleson, Kyle; Landis, Charles; Reddy, K Rajender; Brown, Robert S.
  • Fried MW; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Crawford JM; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Mospan AR; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Watkins SE; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Munoz B; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Zink RC; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Elliott S; Elliott Health Information Pros Inc., Cary, North Carolina, USA.
  • Burleson K; TARGET PharmaSolutions Inc., Durham, North Carolina, USA.
  • Landis C; Liver Care and Transplantation Services at University of Washington Medical Center, Seattle, Washington, USA.
  • Reddy KR; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Brown RS; Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine Center for Liver Disease, New York, New York, USA.
Clin Infect Dis ; 72(10): e558-e565, 2021 05 18.
Article in English | MEDLINE | ID: covidwho-1232191
ABSTRACT

BACKGROUND:

As coronavirus disease 2019 (COVID-19) disseminates throughout the United States, a better understanding of the patient characteristics associated with hospitalization, morbidity, and mortality in diverse geographic regions is essential.

METHODS:

Hospital chargemaster data on adult patients with COVID-19 admitted to 245 hospitals across 38 states between 15 February and 20 April 2020 were assessed. The clinical course from admission, through hospitalization, and to discharge or death was analyzed.

RESULTS:

A total of 11 721 patients were included (majority were >60 years of age [59.9%] and male [53.4%]). Comorbidities included hypertension (46.7%), diabetes (27.8%), cardiovascular disease (18.6%), obesity (16.1%), and chronic kidney disease (12.2%). Mechanical ventilation was required by 1967 patients (16.8%). Mortality among hospitalized patients was 21.4% and increased to 70.5% among those on mechanical ventilation. Male sex, older age, obesity, geographic region, and the presence of chronic kidney disease or a preexisting cardiovascular disease were associated with increased odds of mechanical ventilation. All aforementioned risk factors, with the exception of obesity, were associated with increased odds of death (all P values < .001). Many patients received investigational medications for treatment of COVID-19, including 48 patients on remdesivir and 4232 on hydroxychloroquine.

CONCLUSIONS:

This large observational cohort describes the clinical course and identifies factors associated with the outcomes of hospitalized patients with COVID-19 across the United States. These data can inform strategies to prioritize prevention and treatment for this disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Male Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Aged / Humans / Male Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid